ANNUAL ERADICATION RATE OF BISMUTH-CONTAINING QUADRUPLE THERAPY AS SECOND-LINE TREATMENT FOR HELICOBACTER PYLORI INFECTION: A 15-YEAR PROSPECTIVE STUDY AT A TERTIARY HOSPITAL IN KOREA

被引：0
|
作者：
Kim, Nayoung
Yoon, Kichul
Lee, Dong Ho
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1379
引用
收藏
页码：S571 / S571
页数：1
相关论文
共 50 条
  • [41] Tailored eradication vs empirical bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: A comparative,open trial
    Youn I Choi
    Jun Won Chung
    Dong Kyun Park
    Kyoung Oh Kim
    Kwang An Kwon
    Yoon Jae Kim
    Ja Young Seo
    World Journal of Gastroenterology, 2019, (46) : 6743 - 6751
  • [42] Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy
    Min Soo Kim
    Nayoung Kim
    Sung Eun Kim
    Hyun Jin Jo
    Cheol Min Shin
    Young Soo Park
    Dong Ho Lee
    BMC Gastroenterology, 13
  • [43] Tailored eradication vs empirical bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: A comparative, open trial
    Choi, Youn I.
    Chung, Jun Won
    Park, Dong Kyun
    Kim, Kyoung Oh
    Kwon, Kwang An
    Kim, Yoon Jae
    Seo, Ja Young
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (46) : 6743 - 6751
  • [44] Empiric "Three-in-One" Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern Italy
    Losurdo, Giuseppe
    Lacavalla, Ilaria
    Russo, Francesco
    Riezzo, Giuseppe
    Brescia, Irene Vita
    Rendina, Maria
    Ierardi, Enzo
    Di Leo, Alfredo
    ANTIBIOTICS-BASEL, 2022, 11 (01):
  • [45] SECOND-LINE RESCUE THERAPY WITH LEVOFLOXACIN AND BISMUTH AFTER FAILURE OF A HELICOBACTER PYLORI ERADICATION TREATMENT
    Gisbert, J. P.
    Solis-Munoz, P.
    Romano, M.
    Gravina, A.
    Lucendo, A.
    Molina-Infante, J.
    Velayos, B.
    Herranz, M.
    Barrio, J.
    Modolell, I.
    Gomez, J.
    Del Castillo, F.
    Dominguez, J. L.
    Federico, A.
    Martorano, M.
    Angueira, T.
    Fernandez-Salazar, L.
    Miranda, A.
    Marin, A. C.
    McNicholl, A. G.
    HELICOBACTER, 2014, 19 : 135 - 135
  • [46] RIFABUTIN CONTAINING TRIPLE THERAPY VS. RIFABUTIN AND BISMUTH-CONTAINING QUADRUPLE THERAPY FOR THIRD-LINE TREATMENT OF HELICOBACTER PYLORI (H. PYLORI) INFECTION
    Tavani, R.
    Ciccaglione, A. F.
    Cellini, L.
    Grossi, L.
    Di Tullio, A. M.
    Pagliaro, M.
    Cocciolillo, S.
    Sepe, A.
    Di Berardino, M.
    Marzio, L.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : S111 - S111
  • [47] Moxifloxacin Containing Triple Therapy vs. Moxifloxacin and Bismuth-Containing Quadruple Therapy for First-Line Treatment of Helicobacter pylori (H. pylori) Infection
    Ciccaglione, Antonio Francesco
    Cellini, Luigina
    Grossi, Laurino
    Di Tullio, Ada Maria
    Pagliaro, Mauro
    Tavani, Roberta
    Cocciolillo, Sila
    Marzio, Leonardo
    GASTROENTEROLOGY, 2012, 142 (05) : S482 - S482
  • [48] Moxifloxacin-Containing Triple Therapy as Second-Line Treatment for Helicobacter pylori Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate
    Yoon, Hyuk
    Kim, Nayoung
    Lee, Byoung Hwan
    Hwang, Tae Jun
    Lee, Dong Ho
    Park, Young Soo
    Nam, Ryoung Hee
    Jung, Hyun Chae
    Song, In Sung
    HELICOBACTER, 2009, 14 (05) : 77 - 85
  • [49] RECENT ERADICATON RATE OF MOXIFLOXACIN-CONTAINING TRIPLE THERAPY AS SECOND-LINE TREATMENT FOR HELICOBACTER PYLORI IN KOREA
    Lee, S.
    Lim, J.
    Lee, D.
    Seol, S.
    Kim, N.
    Park, Y.
    Shin, C.
    Cho, H.
    HELICOBACTER, 2012, 17 : 118 - 118
  • [50] Modified quadruple therapy versus bismuth-containing quadruple therapy in first-line treatment of Helicobacter pylori infection in Korea; rationale and design of an open-label, multicenter, randomized controlled trial
    Lim, Hyun
    Bang, Chang Seok
    Shin, Woon Geon
    Choi, Jae Ho
    Soh, Jae Seung
    Kang, Ho Suk
    Yang, Young Joo
    Hong, Ji Taek
    Shin, Suk Pyo
    Suk, Ki Tae
    Lee, Jae Jun
    Baik, Gwang Ho
    Kim, Dong Joon
    MEDICINE, 2018, 97 (46)
12345